Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2014; 20(18): 5353-5362
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5353
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5353
Table 1 Inclusion criteria for liver transplantation in human immunodeficiency virus - positive patients
Absolute CD4 T cell count above 200 cells/mmc, if history of opportunistic infections or AIDS-defining malignancies | Progressive multifocal leukoencephalopathy, chronic intestinal cryptosporidiosis (> 1 mo duration) |
Absolute CD4 T cell count above 100 cells/mmc if absence of previous documented opportunistic infections | Lymphoma or other neoplasms, unless an adequate disease-free period is documented |
Undetectable HIV-RNA in blood for patients on C-ART; if not on C-ART, previous documentation of efficacious therapy or genotypic/phenotypic resistance test documenting available post-LT C-ART options | |
No active (< 1 yr) opportunistic infections, no wasting syndrome or severe malnutrition | |
Compliance to therapies and to follow-up visits |
- Citation: Baccarani U, Righi E, Adani GL, Lorenzin D, Pasqualucci A, Bassetti M, Risaliti A. Pros and cons of liver transplantation in human immunodeficiency virus infected recipients. World J Gastroenterol 2014; 20(18): 5353-5362
- URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5353.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i18.5353